Selective Bronchial Intubation (SBI)

Selective Bronchial Tube Clinical Trial

— SBI  

Official title:

Selective Bronchial Intubation (SBI) at Marie Lannelongue Hospital (HML) : Epidemiology of Expected and Unexpected Difficult Intubations.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03204656
• Other study ID #: 2016-A02070-51
• Status: Completed
• Phase: N/A
• First received: March 22, 2017
• Last updated: June 28, 2017
• Start date: February 20, 2017
• Est. completion date: May 20, 2017

Study information

• Verified date: May 2017
• Source: Centre Chirurgical Marie Lannelongue
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Difficult orotracheal intubation carries a risk of hemodynamic collapse, neurological sequelae secondary to cerebral anoxia or death. Anesthetic scores and predictive indices are used to predict difficulties and avoid complications for usual tracheal intubation. However, existing indices are not adapted to selective bronchial intubations.

The aim of the study is to determine the incidence of unexpected difficult SBI using conventional screening tests. It is a prospective descriptive epidemiological monocentric study comparing two groups of patients (selective vs. non selective intubations).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: May 20, 2017
• Est. primary completion date: May 20, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• For adult patients : age greater than or equal to 18 years

• Patients with thoracic, cardiac, vascular or plastic surgery

Exclusion Criteria:

• Intubations performed before admission to the operating room or catheterization room;

• Patient whose age is less than 18 years

• Traditional re-intubation at the end of the procedure after a selective lung IOT;

• Selective re-intubation in a patient previously intubated on arrival at the operating theater;

• IOT in other departments of the HML (intensive care, Pulmonary Postoperative Unit (UPOP), bronchoscopy, hospitalization services, Intensive Care Unit (ICU), etc.).

Related Conditions & MeSH terms

• Selective Bronchial Tube

Locations

Country	Name	City	State
France	Hôpital Marie Lannelongue	Le Plessis Robinson

Sponsors (1)

Lead Sponsor	Collaborator
Centre Chirurgical Marie Lannelongue

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of difficult selective bronchial intubation	Rate (percentage)	1 day
Secondary	Predictive factors of difficult selective bronchial intubation	questionnaire	1 day